3Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin[J]. Br J Dermatol, 1956, 68(11): 355-361.
4Melish ME, Glasgow LA. The staphylococcal scalded-skin syndrome.[J]. N Engl J Med, 1970, 282(20): 1114-1119.
5Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme[J]. Arch Dermatol, 1993, 129(1): 92-96.
6Kelly JP, Auquier A, Rzany B, et al. An international collaborative case-control study of severe cutaneous adverse reactions (SCAR).Design and methods[J]. J Clin Epidemiol, 1995, 48(9): 1099-1108.
7Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis[J]. N Engl J Med, 1995, 333(24): 1600-1607.
8Dietrich A, Kawakubo Y, Rzany B, et al. Low N-acetylating capacity in patients with Stevens-Johnson syndrome and toxic epidermal neerolysis[J]. Exp Dermatol,1995, 4(5): 313-316.
9Paul C, Wolkenstein P, Adle H, et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis [J]. Br J Dermatol, 1996, 134(4): 710-714.
10Patterson R, Miller M, Kaplan M, et al. Effectiveness of early therapy with corticosteroids in Stevens -Johnson syndrome:experience with 41 cases and a hypothesis regarding pathogenesis
